داروسازی اکسیر
دلر | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 28,290 2.98
Close Price: 28,370
Income Statement
AGM
Interim
2026/06/28 Fiscal Year 2026/03/2012 Month | 2025/05/31 Fiscal Year 2025/03/2012 Month | 2024/05/29 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 57.933 Trillion | 41.856 Trillion | 37.704 Trillion | |
Total Revenues | 57.933 Trillion | 41.856 Trillion | 37.704 Trillion | |
Cost of Goods Sold | 31.801 Trillion | 24.005 Trillion | 21.081 Trillion | |
Gross Profit | 26.132 Trillion | 17.85 Trillion | 16.623 Trillion | |
General & Administrative Expenses | 1.943 Trillion | 1.321 Trillion | 849.371 Billion | |
Net Operating Income & Expenses | 124.844 Billion | 61.253 Billion | -12.921 Billion | |
Operating Profit (Loss) | 24.314 Trillion | 16.591 Trillion | 15.76 Trillion | |
Profit Before Tax | 19.992 Trillion | 12.493 Trillion | 12.284 Trillion | |
Tax | 4.494 Trillion | 2.202 Trillion | 2.272 Trillion | |
Net Profit (Loss) After Tax | 15.498 Trillion | 10.291 Trillion | 10.012 Trillion | |
Retained Earnings at Beginning of Period | 14.137 Trillion | 10.861 Trillion | 8.649 Trillion | |
Approved Dividends — Prior Year AGM | -7.999 Trillion | -7.02 Trillion | -7.785 Trillion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | -3.6 Trillion | - | - | |
Transfer from Other Equity Items | 18.189 Billion | 5.246 Billion | -15.408 Billion | |
Allocable Profit | 18.055 Trillion | 14.137 Trillion | 10.861 Trillion | |
Legal Reserve | 696.7 Billion | - | - | |
Approved Dividends — Current Year | 8.664 Trillion | 7.999 Trillion | 7.02 Trillion | |
Retained Earnings at End of Period | 8.694 Trillion | 6.138 Trillion | 3.841 Trillion |